A citation-based method for searching scientific literature

Louis Monnier, Anne Wojtusciszyn, Claude Colette, David Owens. Diabetes Technol Ther 2011
Times Cited: 109







List of co-cited articles
681 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Trajectories of fasting plasma glucose variability and mortality in type 2 diabetes.
Chia-Lin Lee, Wayne Huey-Herng Sheu, I-Te Lee, Shih-Yi Lin, Wen-Miin Liang, Jun-Sing Wang, Yu-Fen Li. Diabetes Metab 2018
20
25




Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
Roy W Beck, Tonya D Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B McGill, William Polonsky, David Price, Stephen Aronoff,[...]. Ann Intern Med 2017
158
5

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
761
5

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
199
5

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
109
5

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Hsin-Chieh Yeh, Todd T Brown, Nisa Maruthur, Padmini Ranasinghe, Zackary Berger, Yong D Suh, Lisa M Wilson, Elisabeth B Haberl, Jessica Brick, Eric B Bass,[...]. Ann Intern Med 2012
284
4

Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers.
Irl B Hirsch, Stephanie A Amiel, Ian R Blumer, Bruce W Bode, Steven V Edelman, Jane J Seley, Carol A Verderese, Eric S Kilpatrick. Diabetes Technol Ther 2012
16
25

The T1D Exchange clinic registry.
Roy W Beck, William V Tamborlane, Richard M Bergenstal, Kellee M Miller, Stephanie N DuBose, Callyn A Hall. J Clin Endocrinol Metab 2012
302
4

Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants.
Kellee M Miller, Roy W Beck, Richard M Bergenstal, Robin S Goland, Michael J Haller, Janet B McGill, Henry Rodriguez, Jill H Simmons, Irl B Hirsch. Diabetes Care 2013
265
4

The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
Roy W Beck, Irl B Hirsch, Lori Laffel, William V Tamborlane, Bruce W Bode, Bruce Buckingham, Peter Chase, Robert Clemons, Rosanna Fiallo-Scharer, Larry A Fox,[...]. Diabetes Care 2009
258
4

Should minimal blood glucose variability become the gold standard of glycemic control?
Irl B Hirsch, Michael Brownlee. J Diabetes Complications 2005
281
4


Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
S E Inzucchi, R M Bergenstal, J B Buse, M Diamant, E Ferrannini, M Nauck, A L Peters, A Tsapas, R Wender, D R Matthews. Diabetologia 2012
975
4

Glycemic variability: should we and can we prevent it?
Louis Monnier, Claude Colette. Diabetes Care 2008
148
4

Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.
Rikke Borg, Judith C Kuenen, Bendix Carstensen, Hui Zheng, David M Nathan, Robert J Heine, Jorn Nerup, Knut Borch-Johnsen, Daniel R Witte. Diabetes 2010
58
6

Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT.
S E Siegelaar, E S Kilpatrick, A S Rigby, S L Atkin, J B L Hoekstra, J H Devries. Diabetologia 2009
48
8

No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients.
Sarah E Siegelaar, Temo Barwari, Wim Kulik, Joost B Hoekstra, J Hans DeVries. J Diabetes Sci Technol 2011
33
12

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study.
Franco Cavalot, Andrea Pagliarino, Manuela Valle, Leonardo Di Martino, Katia Bonomo, Paola Massucco, Giovanni Anfossi, Mariella Trovati. Diabetes Care 2011
188
4

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.
Katherine Esposito, Francesco Nappo, Raffaele Marfella, Giovanni Giugliano, Francesco Giugliano, Myriam Ciotola, Lisa Quagliaro, Antonio Ceriello, Dario Giugliano. Circulation 2002
4


Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.
Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina,[...]. Diabetes Care 2011
112
4

Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.
Graham P Leese, Jixian Wang, Janice Broomhall, Paul Kelly, Andrew Marsden, William Morrison, Brian M Frier, Andrew D Morris. Diabetes Care 2003
390
4


Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.
R E Ratner, S C L Gough, C Mathieu, S Del Prato, B Bode, H Mersebach, L Endahl, B Zinman. Diabetes Obes Metab 2013
226
4

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
4

Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
Morgan Bron, Maryna Marynchenko, Hongbo Yang, Andrew P Yu, Eric Q Wu. Postgrad Med 2012
57
7

Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey.
K Akram, U Pedersen-Bjergaard, B Carstensen, K Borch-Johnsen, B Thorsteinsson. Diabet Med 2006
72
5

Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia?
Teresa P Monsod, Daniel E Flanagan, Fran Rife, Rebecca Saenz, Sonia Caprio, Robert S Sherwin, William V Tamborlane. Diabetes Care 2002
126
4

Hypoglycemia, diabetes, and cardiovascular events.
Cyrus V Desouza, Geremia B Bolli, Vivian Fonseca. Diabetes Care 2010
248
4


The incidence and costs of hypoglycemia in type 2 diabetes.
Brian J Quilliam, Jason C Simeone, A Burak Ozbay, Stephen J Kogut. Am J Manag Care 2011
62
6

Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes.
Matthew Riddle, Guillermo Umpierrez, Andres DiGenio, Rong Zhou, Julio Rosenstock. Diabetes Care 2011
153
4


Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.
Klaus-Dieter Kohnert, Petra Augstein, Eckhard Zander, Peter Heinke, Karolina Peterson, Ernst-Joachim Freyse, Roman Hovorka, Eckhard Salzsieder. Diabetes Care 2009
72
5

Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Andrea O Y Luk, Ronald C W Ma, Eric S H Lau, Xilin Yang, Winnie W Y Lau, Linda W L Yu, Francis C C Chow, Juliana C N Chan, Wing-Yee So. Diabetes Metab Res Rev 2013
78
5

The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up.
Toshiko Takao, Takehiko Ide, Hiroyuki Yanagisawa, Masatoshi Kikuchi, Shoji Kawazu, Yutaka Matsuyama. Diabetes Res Clin Pract 2010
39
10

Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes.
Klaus-Dieter Kohnert, Petra Augstein, Peter Heinke, Eckhard Zander, Karolina Peterson, Ernst-Joachim Freyse, Eckhard Salzsieder. Diabetes Res Clin Pract 2007
44
9

Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes.
Rohana J Wright, David E Newby, David Stirling, Christopher A Ludlam, Ian A Macdonald, Brian M Frier. Diabetes Care 2010
118
4

Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals.
Nino Gogitidze Joy, Maka S Hedrington, Vanessa J Briscoe, Donna B Tate, Andrew C Ertl, Stephen N Davis. Diabetes Care 2010
129
4

Prediction of severe hypoglycemia.
Daniel J Cox, Linda Gonder-Frederick, Lee Ritterband, William Clarke, Boris P Kovatchev. Diabetes Care 2007
84
4

Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.
Elaine Chow, Alan Bernjak, Scott Williams, Robert A Fawdry, Steve Hibbert, Jenny Freeman, Paul J Sheridan, Simon R Heller. Diabetes 2014
218
4

A method for assessing quality of control from glucose profiles.
N R Hill, P C Hindmarsh, R J Stevens, I M Stratton, J C Levy, D R Matthews. Diabet Med 2007
83
4

Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction.
Gong Su, Shu-hua Mi, Hong Tao, Zhao Li, Hong-Xia Yang, Hong Zheng, Yun Zhou, Lei Tian. Diabetes Care 2013
84
4

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.
M Hanefeld, S Fischer, U Julius, J Schulze, U Schwanebeck, H Schmechel, H J Ziegelasch, J Lindner. Diabetologia 1996
701
4

Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemia.
Itamar Raz, Antonio Ceriello, Peter W Wilson, Chakib Battioui, Eric W Su, Lisa Kerr, Cate A Jones, Zvonko Milicevic, Scott J Jacober. Diabetes Care 2011
59
6

National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011.
Kasia J Lipska, Joseph S Ross, Yun Wang, Silvio E Inzucchi, Karl Minges, Andrew J Karter, Elbert S Huang, Mayur M Desai, Thomas M Gill, Harlan M Krumholz. JAMA Intern Med 2014
249
4

Role of hyperglycemia in nitrotyrosine postprandial generation.
Antonio Ceriello, Lisa Quagliaro, Barbara Catone, Roberta Pascon, Marta Piazzola, Bruno Bais, Giampiero Marra, Laura Tonutti, Claudio Taboga, Enrico Motz. Diabetes Care 2002
175
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.